Naltrexone Attenuates the Antiparkinsonian Effects of Picotesla Range Magnetic Fields

References

• Agid Y., Javoy‐Agid F. Peptides and Parkinson's disease. Trends in Neurosciences 1985; 5: 30–35
   Web of Science ®Google Scholar
• Agnoli A., Ruggeri S., Falaschi P., Mearelli S., Del Roscio S., D'Urso R., Frajese G. Are the enkephalins involved in Parkinson's disease? Clinical and neuroendocrine response to naloxone administration. Advances in biochemical psychopharmacology, E. Costa, M. Trabucchi. Raven Press, New York 1980; vol. 22: 511–521
   Google Scholar
• Akil H., Watson S. J., Young E., Lewis M. E., Walker J. M. Endogenous opioids: biology and function. Annual Review of Neuroscience 1984; 7: 223–255
   PubMed Web of Science ®Google Scholar
• Bar‐Or A., Brown G. M. Pineal involvement in the diurnal rhythm of nociception in the rat. Life Sciences 1989; 44: 1067–1075
   PubMed Web of Science ®Google Scholar
• Bloom F., Segal D., Ling N. Endorphine profound behavioral effects in rats suggest new etiological factors in mental illness. Science 1976; 194: 630–632
   PubMed Web of Science ®Google Scholar
• Bradbury A. J., Kelly M. E., Smith J. A. Melatonin action in the mid‐brain can regulate dopamine function both behaviourally and biochemically. The pineal gland: endocrine aspects, G. M. Brown, S. D. Wainwright. Oxford Pergamon Press. 1985; 327–332
   Google Scholar
• Burton S., Daya S., Potgieter B. Melatonin modulates apomorphine‐induced rotational behaviour. Experientia 1991; 47: 466–469
   PubMedGoogle Scholar
• Cardinali D. P., Vacas M. I., Estevez‐Boyer E. Specific binding for melatonin in bovine brain. Endocrinology 1979; 105: 437–441
   PubMed Web of Science ®Google Scholar
• Cotzias G. C., Tang L. C., Miller S. T., Ginos J. Z. Melatonin and abnormal movement induced by L‐dopa in mice. Science 1971; 173: 450–452
   PubMed Web of Science ®Google Scholar
• Cremer‐Bartels G., Krause K., Kuechle H. J. Influence of low magnetic‐field strength variations on the retina and pineal gland of quails and humans. Graefe's Archives of Clinical and Experimental Ophthalmology 1983; 220: 248–252
   PubMed Web of Science ®Google Scholar
• Dafny N., Burks T. F. Opiate and endocrine interaction: morphine effects on hypothalamus and pineal body. Neuroendocrinology 1976; 22: 72–86
   PubMed Web of Science ®Google Scholar
• Demaine C., Semm P. The avian pineal gland as an independent magnetic sensor. Neuroscience Letters 1985; 62: 119–122
   PubMed Web of Science ®Google Scholar
• Diamond B. I., Borison R. L. Enkephalins and nigrostriatal function. Neurology 1978; 28: 1085–1088
   PubMed Web of Science ®Google Scholar
• Dray A. Serotonin in the basal ganglia. Journal of Physiology (Paris) 1981; 77: 393–403
   PubMedGoogle Scholar
• Gaffori O., Van Ree J. M. Serotonin and antidepressant drugs antagonize melatonin‐induced behavioural changes after injection into the nucleus accumbens of rats. Neuropharmacology 1985; 24: 237–244
   PubMed Web of Science ®Google Scholar
• Geffard M., Gaffori O., Chaveau J., Muyard J. P., Le Moal M. Dramatic increase in pineal gland melatonin levels in the rat after subcutaneous injection of des‐tyrosine gamma‐endorphin. Neuroscience Letters 1981; 27: 329–334
   PubMed Web of Science ®Google Scholar
• Iwatsubo K. Narcotic analgesics and nigrostriatal dopaminergic neurons. Trends in Pharmacological Sciences 1983; 3: 64–66
   Web of Science ®Google Scholar
• Jaffe J. H., Martin W. R. Opioid analgesics and antagonists. The pharmacological basis of therapeutics, A. G. Gilman, L. S. Goodman, T. W. Rall, F. Murad. Macmillan Publishing Company, New York 1985; 491–531
   Google Scholar
• Kavaliers M. Opioid peptides, the pineal gland and rhythmic behavior in fishes. Transactions of the American Fishery Society 1984; 113: 432–438
   Web of Science ®Google Scholar
• Kavaliers M., Ossenkopp K. P. Effects of 0.5 Hz and 60 Hz magnetic fields on morphine‐induced behavioral changes in mice. Society of Neuroscience Abstracts 1984; 10: 1105
   Google Scholar
• Kavaliers M., Ossenkopp K. P. Exposure to rotating magnetic fields alters morphine‐induced behavioral responses in two strains of mice. Neuropharmacology 1985; 89: 440–443
   Google Scholar
• Kavaliers M., Ossenkopp K. P. Magnetic fields inhibition of morphine‐induced analgesia and behavioral activity in mice: evidence for involvement of calcium ions. Brain Research 1986a; 379: 830–838
   Web of Science ®Google Scholar
• Kavaliers M., Ossenkopp K. P. Magnetic fields differentially inhibit mu, delta, kappa and sigma opiate‐induced analgesia in mice. Peptides 1986b; 7: 449–453
   PubMed Web of Science ®Google Scholar
• Kavaliers M., Ossenkopp K. P. Stress‐induced opioid analgesia and activity in mice: inhibitory influences of exposure to magnetic fields. Psychopharmacology 1986c; 89: 440–443
   PubMed Web of Science ®Google Scholar
• Kavaliers M., Ossenkopp K. P. Day‐night rhythms of opioid and non‐opioid stress‐induced analgesia: differential inhibitory effects of exposure to magnetic fields. Pain 1987; 32: 223–229
   Web of Science ®Google Scholar
• Kavaliers M., Ossenkopp K. P. Magnetic fields, opioid systems, and day‐night rhythms of behavior. Electromagnetic fields and circadian rhythmicity, M. C. Moore‐Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 95–117
   Google Scholar
• Kavaliers M., Hirst M., Teskey G. C. Ageing, opioid analgesia and the pineal gland. Life Sciences 1983; 32: 2279–2287
   PubMed Web of Science ®Google Scholar
• Kirk A., Kertesz A. On drawing impairment in Alzheimer's disease. Archives of Neurology 1991; 48: 73–77
   PubMed Web of Science ®Google Scholar
• Lakin M., Miller C. H., Scott M. L., Winter W. D. Involvement of the pineal gland and melatonin in murine analgesia. Life Sciences 1981; 29: 2543–2551
   PubMed Web of Science ®Google Scholar
• Laudon M., Nir I., Zisapel N. Melatonin receptors in discrete brain areas of the male rat. Impact of aging on density and on circadian rhythmicity. Neuroendocrinology 1988; 48: 577–583
   PubMed Web of Science ®Google Scholar
• Lezak M. D. Neuropsychological assessmentsecond Edition. Oxford University Press, New York 1985; 68–69; 382–413
   Google Scholar
• Lissoni P., Esposti D., Esposti G., Mauri R., Resentini M., Morabito F., Fumagali P., Santagostino A., Delitala G., Fraschini F. A clinical study on the relationship between the pineal gland and the opioid system. Journal of Neural Transmission 1986; 65: 63–73
   PubMed Web of Science ®Google Scholar
• Loh H. H., Brase D. A., Sampath‐Khanna S. Beta‐endorphin in vitro inhibition of striatal dopamine release. Nature 1976; 268: 745–747
   Google Scholar
• Lowenstein P. R., Pereyra E. N., Gonzalez Solveyra C., Cardinali D. P. Effect of naloxone on the nocturnal rise of rat pineal melatonin content. European Journal of Pharmacology 1984; 98: 261–264
   PubMed Web of Science ®Google Scholar
• Mayeux R., Stern Y., Cote L., Williams J. B. W. Altered serotonin metabolism in depressed patients with Parkinson's disease. Neurology 1984; 34: 642–646
   PubMed Web of Science ®Google Scholar
• McCance‐Katz E. F., Marek K. L., Price L. H. Serotonergic dysfunction in depression associated with Parkinson's disease. Neurology 1992; 42: 1813–1814
   PubMed Web of Science ®Google Scholar
• Moore‐Ede M. C., Campbell S. S., Reiter R. J. Introduction. Electromagnetic fields and circadian rhythmicity, M. C. Moore‐Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 3–10
   Google Scholar
• Nappi G., Petraglia F., Martignoni E., Facchinetti F., Bono G., Genazzani A. R. Beta‐endorphin cerebrospinal fluid decrease in untreated parkinsonian patients. Neurology 1985; 35: 1371–1374
   PubMed Web of Science ®Google Scholar
• Niles L. P., Wong Y. W., Mishra R. K., Brown G. M. Melatonin receptors in brain. European Journal of Pharmacology 1973; 55: 219–220
   Web of Science ®Google Scholar
• Ogawa N., Yamamoto M. Neurotransmitters and their receptors in Parkinsonism. Current problems in treatment of parkinson's disease, Y. Kuroiwa, Y. Toyokura. DMW, Japan 1985; 23–32
   Google Scholar
• Ogawa N., Yamawaki Y., Kuroda H., Ofuji T. Effects of bromocriptine on receptor binding of methionine‐enkephalin. Neuroscience Letters 1981; 23: 215–218
   PubMed Web of Science ®Google Scholar
• Olcese J., Reuss S. Magnetic field effects on pineal gland synthesis: comparative studies on albino and pigmented rodents. Brain Research 1986; 369: 365–369
   PubMed Web of Science ®Google Scholar
• Olcese J., Reuss S., Vollrath L. Evidence for the involvement of the visual system in mediating magnetic field effect on pineal melatonin synthesis in the rat. Brain Research 1985; 333: 382–384
   PubMed Web of Science ®Google Scholar
• Olcese J., Reuss S., Semm P. Geomagnetic field detection in rodents. Life Sciences 1988; 42: 605–613
   PubMed Web of Science ®Google Scholar
• Ossenkopp K. P., Kavaliers M. Morphine‐induced analgesia and exposure to low‐intensity 60‐Hz magnetic fields: inhibition of nocturnal analgesia in mice is a function of magnetic field intensity. Brain Research 1987; 418: 356–360
   PubMed Web of Science ®Google Scholar
• Ossenkopp K. P., Kavaliers M. Clinical and applied aspects of magnetic field exposure: a possible role for endogenous opioid systems. Journal of Bioelectrics 1988; 7: 189–208
   Web of Science ®Google Scholar
• Ossenkopp K. P., Kavaliers M., Hirst M. Reduced morphine analgesia in mice following a geomagnetic disturbance. Neuroscience Letters 1983; 40: 321–325
   PubMed Web of Science ®Google Scholar
• Ossenkopp K. P., Kavaliers M., Prato F. S., Teskey G. C., Sestini E., Hirst M. Exposure to nuclear magnetic resonance imaging procedures attenuates morphine‐induced analgesia in mice. Life Sciences 1985; 37: 1507–1514
   PubMed Web of Science ®Google Scholar
• Pert C. B., Kuhar M. J., Snyder S. H. Opiate receptors: autoradiographic localization in rat brain. Proceedings of the National Academy of Science USA 1976; 73: 3729–3733
   PubMed Web of Science ®Google Scholar
• Pezzoli G., Panerai A. E., Di Giulio A., Longo A., Passerini D., Carenzi A. Methionine‐enkephalin, substance P, and homovanillic acid in the CSF of parkinsonian patients. Neurology 1984; 34: 516–519
   PubMed Web of Science ®Google Scholar
• Pollard H., Llorens C., Schwartz J. C., Gros C., Dray F. Localization of opiate receptors and enkephalins in rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies. Brain Research 1978; 151: 392–398
   PubMed Web of Science ®Google Scholar
• Quinn N., Critchley P., Marsden C. D. Young onset Parkinson's disease. Movement Disorders 1987; 2: 73–91
   PubMedGoogle Scholar
• Rozencwaig R., Grad B. R., Ochoa J. The role of melatonin and serotonin in aging. Medical Hypotheses 1987; 23: 337–352
   PubMed Web of Science ®Google Scholar
• Rudolph K., Wirz‐Justice A., Krauchi K., Feer H. Static magnetic fields decrease nocturnal pineal CAMP in the rat. Brain Research 1988; 446: 159–160
   PubMed Web of Science ®Google Scholar
• Sallanon M., Claustrat B., Touret M. Presence of melatonin in various cat brainstem nuclei determined by radioimmunoassay. Acta Endocrinologica 1982; 101: 161–165
   PubMedGoogle Scholar
• Sandyk R. The endogenous opioid system in neurological disorders of the basal ganglia. Life Sciences 1985; 37: 1655–1663
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields as a novel therapeutic modality in Parkinson's disease (Editorial). International Journal of Neuroscience 1992a; 66: 1–15
   PubMed Web of Science ®Google Scholar
• Sandyk R. Weak magnetic fields in the treatment of Parkinson's disease with the “on‐off phenomenon. International Journal of Neuroscience 1992b; 66: 97–106
   PubMed Web of Science ®Google Scholar
• Sandyk R. Magnetic fields in the therapy of Parkinsonism. International Journal of Neuroscience 1992c; 66: 209–235
   PubMed Web of Science ®Google Scholar
• Sandyk R., Snider S. R. Naloxone ameliorates levodopa‐induced dyskinesias in Parkinson's disease. American Journal of Psychiatry 1986; 143: 118
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Serotonin in involuntary movement disorders. International Journal of Neuroscience 1988; 42: 185–205
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Increased incidence of neuroleptic‐induced movement disorders in pinealectomized rats. International Journal of Neuroscience 1989a; 48: 303–308
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Melatonin potentiates the effects of naloxone on reserpine‐induced catalepsy in the rat. International Journal of Neuroscience 1989b; 48: 125–127
   PubMed Web of Science ®Google Scholar
• Sandyk R., Fisher H. Melatonin mediates the antidyskinetic effects of naloxone in tardive dyskinesia. Journal of Clinical Psychopharmacology 1989c; 9: 147–148
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. The effects of external picoTesla range magnetic fields on the EEG in Parkinson's disease. International Journal of Neuroscience 1993a; 70: 85–96
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Further observations on the unique efficacy of picoTesla magnetic fields in Parkinson's disease. International Journal of Neuroscience 1993b; 69: 167–183
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Enhancement of visuoperceptive functions by picoTesla range magnetic fields in patients with Parkinson's disease. International Journal of Neuroscience 1993; 70: 233–254
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Reversal of micrographia in Parkinson's disease by application of picoTesla range magnetic fields. International Journal of Neuroscience, (in press a)
   Google Scholar
• Sandyk R., Anninos P. A., Tsagas N., Derpapas K. Magnetic fields in the treatment of Parkinson's disease. International Journal of Neuroscience 1992; 63: 141–150
   PubMed Web of Science ®Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth‐strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore‐Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Sheehy M., Schachter M., Marsden C. D., Parkes J. D. Enkephalins in motor disorders. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Tunbridge Wells 1981; 165–169
   Google Scholar
• Simantov R., Kuhar M. J., Pasternak G. W. The regional distribution of a morphine‐like factor enkephalin in monkey brain. Brain Research 1976; 106: 189–197
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Growth hormone response to melatonin in man. Science 1974a; 184: 1373–1374
   PubMed Web of Science ®Google Scholar
• Smythe G. A., Lazarus L. Suppression of HGH secretion by melatonin and cyproheptadine. Journal of Clinical Investigations 1974b; 54: 116–121
   PubMed Web of Science ®Google Scholar
• Trabucchi M., Bassi S., Frattola L. Effect of naloxone on the “on off” syndrome in patients receiving long‐term levodopa therapy. Archives of Neurology 1982; 39: 120–121
   PubMedGoogle Scholar
• Vacas M. I., Cardinali D. P. Diurnal changes in melatonin binding sites of hamster and rat brains. Correlation with neuroendocrine responsiveness to melatonin. Neuroscience Letters 1979; 15: 259–263
   PubMed Web of Science ®Google Scholar
• Vardi J., Flechter S., Regev I. The modulatory effect of opiate receptor inhibitor in parkinsonism. Current Therapy Research 1979; 26: 1015–1018
   Google Scholar
• Wand P., Kuschinsky K., Sontag K. H. Morphine‐induced muscular rigidity in rats. European Journal of Pharmacology 1973; 24: 189–193
   PubMed Web of Science ®Google Scholar
• Weil‐Fugazza J. Central metabolism and release of serotonin in pain and analgesia. Serotonin and pain, J. M. Besson. Elsevier Science Publishers B. V., Amsterdam 1990; 221–238, (Biomedical Division)
   Google Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C., Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N‐acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Anderson L. E., Hilton D. I., Phillips R. D. Chronic exposure to 60‐Hz electric fields: effects on pineal function in the rat. Bioelectromagnetics 1981; 2: 371–380
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Chess E. K., Anderson L. E. 60‐Hz electric‐field effects on pineal melatonin rhythms: time course for onset and recovery. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Yokochi M., Narabayashi H. Clinical characteristics of juvenile Parkinsonism. Research progress in parkinson's disease, F. C. Rose, R. Capildeo. Pitman Medical, Tunbridge, Wells 1981; 35–39
   Google Scholar
• Zamir N., Skofitsch G., Bannon M. J., Helke C. J., Kopin I. J., Jacobowitz D. M. Primate model of Parkinson's disease: alterations in multiple opioid systems in the basal ganglia. Brain Research 1987; 322: 356–360
   Google Scholar
• Zatz M., Brownstein M. J. Central depressants rapidly reduce nocturnal serotonin‐N‐acetyltransferase activity in the rat pineal gland. Brain Research 1979; 160: 381–386
   PubMed Web of Science ®Google Scholar
• Zisapel N., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus: regulation of calcium entry. Brain Research 1983; 272: 378–381
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition of dopamine release by melatonin: regional distribution in the rat brain. Brain Research 1982; 246: 161–163
   PubMed Web of Science ®Google Scholar
• Zisapel N., Egozi Y., Laudon M. Inhibition by melatonin of dopamine release from rat hypothalamus in vitro: variations with sex and the estrous cycle. Neuroendocrinology 1983; 37: 41–47
   PubMed Web of Science ®Google Scholar